Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiographic Image Enhancement | 15 | 2010 | 25 | 2.750 |
Why?
|
| Cartilage, Articular | 17 | 2011 | 265 | 2.540 |
Why?
|
| X-Ray Diffraction | 10 | 2010 | 12 | 1.860 |
Why?
|
| Ankle Joint | 6 | 2010 | 38 | 0.960 |
Why?
|
| Foot | 5 | 2010 | 40 | 0.930 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 5 | 2010 | 28 | 0.930 |
Why?
|
| Talus | 5 | 2010 | 12 | 0.890 |
Why?
|
| Tendons | 5 | 2009 | 164 | 0.690 |
Why?
|
| Cartilage | 3 | 2009 | 70 | 0.630 |
Why?
|
| Osteoarthritis | 4 | 2010 | 277 | 0.610 |
Why?
|
| Ankle | 3 | 2010 | 19 | 0.600 |
Why?
|
| Connective Tissue | 3 | 2009 | 19 | 0.590 |
Why?
|
| Intervertebral Disc | 9 | 2018 | 113 | 0.520 |
Why?
|
| Arthrography | 4 | 2006 | 22 | 0.500 |
Why?
|
| Bone and Bones | 3 | 2004 | 108 | 0.470 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2007 | 63 | 0.370 |
Why?
|
| Chondrocytes | 2 | 2009 | 97 | 0.350 |
Why?
|
| Knee | 1 | 2010 | 38 | 0.330 |
Why?
|
| Tissue Donors | 1 | 2010 | 61 | 0.320 |
Why?
|
| Rabbits | 10 | 2018 | 161 | 0.320 |
Why?
|
| Radiography | 7 | 2014 | 522 | 0.320 |
Why?
|
| Etidronic Acid | 1 | 2009 | 4 | 0.310 |
Why?
|
| Achilles Tendon | 1 | 2009 | 6 | 0.300 |
Why?
|
| Humans | 26 | 2014 | 22592 | 0.300 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 12 | 0.300 |
Why?
|
| Foot Bones | 1 | 2008 | 1 | 0.300 |
Why?
|
| Bone Resorption | 1 | 2009 | 75 | 0.290 |
Why?
|
| Ossification, Heterotopic | 1 | 2008 | 32 | 0.290 |
Why?
|
| Animals | 15 | 2018 | 3238 | 0.290 |
Why?
|
| Chondrocalcinosis | 1 | 2008 | 3 | 0.290 |
Why?
|
| Uric Acid | 1 | 2008 | 7 | 0.290 |
Why?
|
| Refractometry | 2 | 2008 | 2 | 0.290 |
Why?
|
| Intervertebral Disc Degeneration | 3 | 2018 | 74 | 0.280 |
Why?
|
| Knee Joint | 4 | 2010 | 566 | 0.270 |
Why?
|
| Osteoarthritis, Knee | 3 | 2010 | 292 | 0.270 |
Why?
|
| Tendon Injuries | 1 | 2009 | 151 | 0.260 |
Why?
|
| Joint Capsule | 1 | 2007 | 35 | 0.260 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 80 | 0.250 |
Why?
|
| Elbow Joint | 1 | 2007 | 113 | 0.240 |
Why?
|
| Cartilage Diseases | 1 | 2005 | 42 | 0.220 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 431 | 0.220 |
Why?
|
| Reproducibility of Results | 7 | 2009 | 578 | 0.220 |
Why?
|
| Cadaver | 4 | 2009 | 274 | 0.210 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 512 | 0.210 |
Why?
|
| Femur Head | 1 | 2004 | 43 | 0.210 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 79 | 0.210 |
Why?
|
| Musculoskeletal System | 1 | 2003 | 5 | 0.200 |
Why?
|
| Metatarsal Bones | 1 | 2003 | 4 | 0.200 |
Why?
|
| Algorithms | 2 | 2008 | 290 | 0.200 |
Why?
|
| Middle Aged | 10 | 2011 | 7800 | 0.200 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 1 | 0.200 |
Why?
|
| Activin Receptors, Type II | 1 | 2002 | 1 | 0.200 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 3 | 0.200 |
Why?
|
| Proteoglycans | 4 | 2007 | 119 | 0.190 |
Why?
|
| Adipose Tissue | 1 | 2003 | 72 | 0.190 |
Why?
|
| Proteins | 1 | 2002 | 52 | 0.190 |
Why?
|
| Male | 11 | 2011 | 12260 | 0.180 |
Why?
|
| Spinal Diseases | 3 | 2007 | 106 | 0.170 |
Why?
|
| Intervertebral Disc Displacement | 3 | 2006 | 74 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2011 | 3657 | 0.170 |
Why?
|
| X-Ray Intensifying Screens | 2 | 2010 | 2 | 0.160 |
Why?
|
| Female | 9 | 2018 | 12734 | 0.160 |
Why?
|
| Adult | 6 | 2011 | 6826 | 0.160 |
Why?
|
| Aged | 7 | 2011 | 7300 | 0.160 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 333 | 0.160 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Hyperalgesia | 1 | 2018 | 44 | 0.140 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2014 | 8 | 0.140 |
Why?
|
| Radiculopathy | 1 | 2018 | 41 | 0.140 |
Why?
|
| Cicatrix | 2 | 2006 | 8 | 0.130 |
Why?
|
| Sex Factors | 2 | 2010 | 380 | 0.120 |
Why?
|
| Lumbar Vertebrae | 3 | 2011 | 353 | 0.120 |
Why?
|
| Scattering, Radiation | 2 | 2006 | 31 | 0.110 |
Why?
|
| Adolescent | 3 | 2011 | 1855 | 0.110 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 38 | 0.100 |
Why?
|
| Prevalence | 2 | 2011 | 372 | 0.100 |
Why?
|
| Equipment Design | 2 | 2009 | 119 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 200 | 0.090 |
Why?
|
| Thumb | 2 | 2014 | 5 | 0.090 |
Why?
|
| Zygapophyseal Joint | 1 | 2011 | 27 | 0.090 |
Why?
|
| Collagen | 3 | 2010 | 78 | 0.090 |
Why?
|
| Glycosaminoglycans | 1 | 2010 | 18 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2010 | 48 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 3 | 2007 | 28 | 0.080 |
Why?
|
| Calcinosis | 1 | 2010 | 43 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 129 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2009 | 3 | 0.080 |
Why?
|
| ADAM Proteins | 1 | 2009 | 37 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 76 | 0.080 |
Why?
|
| Dogs | 2 | 2006 | 137 | 0.080 |
Why?
|
| Swine, Miniature | 1 | 2009 | 6 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2009 | 19 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2009 | 13 | 0.080 |
Why?
|
| Swine | 1 | 2009 | 67 | 0.080 |
Why?
|
| South Africa | 1 | 2008 | 7 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2010 | 800 | 0.070 |
Why?
|
| Tomography, X-Ray | 1 | 2008 | 2 | 0.070 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 193 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 623 | 0.070 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 8 | 0.070 |
Why?
|
| Ankle Injuries | 1 | 2008 | 8 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 789 | 0.070 |
Why?
|
| Metals | 1 | 2008 | 99 | 0.070 |
Why?
|
| Cattle | 4 | 2010 | 112 | 0.070 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2007 | 4 | 0.070 |
Why?
|
| Intervertebral Disc Chemolysis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Phantoms, Imaging | 2 | 2006 | 29 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Collagen Type III | 1 | 2007 | 8 | 0.070 |
Why?
|
| Metalloproteases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Antigens | 1 | 2007 | 9 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 127 | 0.070 |
Why?
|
| Contracture | 1 | 2007 | 11 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2006 | 8 | 0.060 |
Why?
|
| Gait | 1 | 2010 | 379 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 618 | 0.060 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2006 | 3 | 0.060 |
Why?
|
| Tissue Adhesions | 1 | 2006 | 9 | 0.060 |
Why?
|
| Thrombin | 1 | 2006 | 14 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 84 | 0.060 |
Why?
|
| Hemostatics | 1 | 2006 | 11 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 98 | 0.060 |
Why?
|
| Laminectomy | 1 | 2006 | 41 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2007 | 467 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 752 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Ligaments, Articular | 1 | 2006 | 84 | 0.060 |
Why?
|
| Observer Variation | 1 | 2005 | 83 | 0.060 |
Why?
|
| Arthritis | 1 | 2004 | 45 | 0.060 |
Why?
|
| Phenazines | 1 | 2004 | 4 | 0.050 |
Why?
|
| Menisci, Tibial | 1 | 2004 | 91 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2004 | 14 | 0.050 |
Why?
|
| Punctures | 2 | 2018 | 9 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 432 | 0.050 |
Why?
|
| Hallux | 1 | 2003 | 2 | 0.050 |
Why?
|
| Ligaments | 1 | 2003 | 10 | 0.050 |
Why?
|
| Biomechanical Phenomena | 3 | 2010 | 514 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2002 | 1 | 0.050 |
Why?
|
| Keratan Sulfate | 1 | 2002 | 15 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 574 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 16 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 119 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 147 | 0.040 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 48 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 130 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2018 | 8 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 16 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2018 | 23 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 19 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 21 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 21 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 67 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 52 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 73 | 0.030 |
Why?
|
| Injections, Spinal | 2 | 2007 | 32 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 30 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 625 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 314 | 0.030 |
Why?
|
| X-Rays | 1 | 2014 | 6 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2014 | 73 | 0.030 |
Why?
|
| Time Factors | 2 | 2007 | 1247 | 0.030 |
Why?
|
| Osteophyte | 1 | 2011 | 4 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 7 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 125 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 2010 | 24 | 0.020 |
Why?
|
| Joint Diseases | 1 | 2011 | 86 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 49 | 0.020 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 11 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 119 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 79 | 0.020 |
Why?
|
| Receptor, trkA | 1 | 2007 | 10 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 9 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 37 | 0.020 |
Why?
|
| Cell Communication | 1 | 2007 | 23 | 0.020 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2006 | 6 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 165 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2006 | 3 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 159 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 58 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 208 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1403 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 144 | 0.020 |
Why?
|
| DNA | 1 | 2006 | 95 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2007 | 280 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 165 | 0.020 |
Why?
|
| Photons | 1 | 2006 | 4 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 1607 | 0.020 |
Why?
|
| United States | 1 | 2011 | 1741 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 229 | 0.010 |
Why?
|
| Wounds, Stab | 1 | 2005 | 2 | 0.010 |
Why?
|
| Needles | 1 | 2005 | 17 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 1062 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2003 | 15 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 804 | 0.010 |
Why?
|